Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-β oligomers - Gandy, Sam; Simon, Adam J.; Steele, John W.; Lublin, Alex L.; Lah, James J.; Walker, Lary C.; Levey, Allan I.; Krafft, Grant A.; Levy, Efrat; Checler, Frédéric; Glabe, Charles; Bilker, Warren B.; et al. (Annals of neurology, 2010)
Keywords: Alzheimer Disease - etiology; Alzheimer Disease - genetics; Alzheimer Disease - pathology; Amyloid beta-Peptides - chemistry; Amyloid beta-Peptides - genetics; Amyloid beta-Peptides - toxicity; Amyloid beta-Protein Precursor - chemistry; Amyloid beta-Protein Precursor - genetics; Amyloid beta-Protein Precursor - toxicity; Animals; Behavior, Animal - drug effects; Behavior, Animal - physiology; Biological and medical sciences; Brain Chemistry - genetics; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases; Disease Models, Animal; Female; Humans; Male; Maze Learning - drug effects; Maze Learning - physiology; Medical sciences; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurology; Peptide Fragments - chemistry; Peptide Fragments - genetics; Peptide Fragments - toxicity; Protein Processing, Post-Translational - genetics; Human; Nervous system diseases; Alzheimer disease; Toxicity; Central nervous system disease; Degenerative disease; Amyloid; Cerebral disorder